Alzheimer's disease Trials in Los Alamitos, United States
Conditions / Alzheimer's disease / Los Alamitos, United States
Research into Alzheimer's disease spans multiple therapeutic approaches and trial phases.
14 total trials for this combination
Showing top 10 of 14 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00006187 | The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease | TERMINATED | PHASE3 |
| NCT02951598 | A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD) | ACTIVE_NOT_RECRUITING | — |
| NCT05557409 | A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation | COMPLETED | PHASE3 |
| NCT05686044 | A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD | COMPLETED | PHASE2/PHASE3 |
| NCT00667810 | Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients | TERMINATED | PHASE3 |
| NCT04797715 | Assessing Clinical Outcomes in Alzheimer's Disease Agitation | COMPLETED | PHASE3 |
| NCT04520412 | A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease | SUSPENDED | PHASE3 |
| NCT04437511 | A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06657768 | A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD) | RECRUITING | PHASE1 |
| NCT03226522 | Addressing Dementia Via Agitation-Centered Evaluation | COMPLETED | PHASE2/PHASE3 |